Home > Financial Ratios > SUVEN PHARMACEUTICALS

SUVEN PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
SUVEN PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SUVEN PHARMACEUTICALS
Please provide your vote to see the results

SUVEN PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) -24.63-7.9547.4313.49134.02

What is the latest Core EBITDA Growth ratio of SUVEN PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of SUVEN PHARMACEUTICALS is -24.63 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar2024-24.63
Mar2023-7.95
Mar202247.43
Mar202113.49
Mar2020134.02

How is Core EBITDA Growth of SUVEN PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2024 -24.63
Negative
Mar2023 -7.95
Negative
Mar2022 47.43
251.59
Mar2021 13.49
-89.93
Mar2020 134.02 -

Other Financial Ratios of SUVEN PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of SUVEN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SUVEN PHARMACEUTICALS ₹29,752.6 Cr 5.5% 5.9% 84.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,084.0 Cr -0% -4.6% 18.9% Stock Analytics
DIVIS LABORATORIES ₹162,384.0 Cr 8.8% 5.1% 64.4% Stock Analytics
CIPLA ₹118,853.0 Cr 2.4% -1.1% 0.8% Stock Analytics
DR REDDYS LABORATORIES ₹103,143.0 Cr 2.6% -9.9% -0.4% Stock Analytics
ZYDUS LIFESCIENCES ₹101,459.0 Cr 3.6% -0.1% 22.7% Stock Analytics


SUVEN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SUVEN PHARMACEUTICALS

5.5%

5.9%

84.6%

SENSEX

0.7%

-0.1%

8.8%


You may also like the below Video Courses